Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Morel

Showing results (31-40 of 197) with videos related to

Pageof 20
Sort By:
Joint Bone Spine|June 29, 2021
Practical management of patients on anti-IL6R therapy - the CRI guidelinesJacques Morel, Anne Tournadre, Jérémie Sellam, et al.
Arthritis Research & Therapy|December 14, 2007
Apoptosis is not the major death mechanism induced by celecoxib on rheumatoid arthritis synovial fibroblastsRachel Audo, Véronique Deschamps, Michael Hahne, et al.
Scientific Reports|August 26, 2023
Long-range fiber-optic earthquake sensing by active phase noise cancellationSebastian Noe, Dominik Husmann, Nils Müller, et al.
The Journal of Rheumatology|March 3, 2012
Short-term risk of total malignancy and nonmelanoma skin cancers with certolizumab and golimumab in patients with rheumatoid arthritis: metaanalysis of randomized controlled trialsPierre LE Blay, Gael Mouterde, Thomas Barnetche, et al.
Clinical and Experimental Rheumatology|December 16, 2016
TNF inhibitors increase fat mass in inflammatory rheumatic disease: a systematic review with meta-analysisSarah Marouen, Thomas Barnetche, Bernard Combe, et al.
Cytokine|December 8, 2014
Targeting the Fas/FasL system in Rheumatoid Arthritis therapy: Promising or risky?Flavia Calmon-Hamaty, Rachel Audo, Bernard Combe, et al.
Joint Bone Spine|August 20, 2011
On the impact of a dedicated educational program for ankylosing spondylitis: effect on patient satisfaction, disease knowledge and spinal mobility, a pilot studyAnne Sudre, Isabelle Tavares Figuereido, Cédric Lukas, et al.
Clinical and Experimental Rheumatology|July 7, 2012
Risk of malignancy including non-melanoma skin cancers with anti-tumor necrosis factor therapy in patients with rheumatoid arthritis: meta-analysis of registries and systematic review of long-term extension studiesPierre Le Blay, Gael Mouterde, Thomas Barnetche, et al.
Presse Medicale (Paris, France : 1983)|May 25, 2010
[Postoperative discitis due to Propionibacterium acnes]Yves-Marie Pers, Johana Chekroun, Cédric Lukas, et al.
Rheumatology (Oxford, England)|August 20, 2009
Mesenteric and splenic cat-scratch disease during etanercept therapyAurélie Schiffmann, Yves Marie Pers, Cédric Lukas, et al.
Pageof 20

Showing results (31-40 of 197) with videos related to

Sort By:
Pageof 20
Joint Bone Spine|June 29, 2021
Practical management of patients on anti-IL6R therapy - the CRI guidelinesJacques Morel, Anne Tournadre, Jérémie Sellam, et al.
Arthritis Research & Therapy|December 14, 2007
Apoptosis is not the major death mechanism induced by celecoxib on rheumatoid arthritis synovial fibroblastsRachel Audo, Véronique Deschamps, Michael Hahne, et al.
Scientific Reports|August 26, 2023
Long-range fiber-optic earthquake sensing by active phase noise cancellationSebastian Noe, Dominik Husmann, Nils Müller, et al.
The Journal of Rheumatology|March 3, 2012
Short-term risk of total malignancy and nonmelanoma skin cancers with certolizumab and golimumab in patients with rheumatoid arthritis: metaanalysis of randomized controlled trialsPierre LE Blay, Gael Mouterde, Thomas Barnetche, et al.
Clinical and Experimental Rheumatology|December 16, 2016
TNF inhibitors increase fat mass in inflammatory rheumatic disease: a systematic review with meta-analysisSarah Marouen, Thomas Barnetche, Bernard Combe, et al.
Cytokine|December 8, 2014
Targeting the Fas/FasL system in Rheumatoid Arthritis therapy: Promising or risky?Flavia Calmon-Hamaty, Rachel Audo, Bernard Combe, et al.
Joint Bone Spine|August 20, 2011
On the impact of a dedicated educational program for ankylosing spondylitis: effect on patient satisfaction, disease knowledge and spinal mobility, a pilot studyAnne Sudre, Isabelle Tavares Figuereido, Cédric Lukas, et al.
Clinical and Experimental Rheumatology|July 7, 2012
Risk of malignancy including non-melanoma skin cancers with anti-tumor necrosis factor therapy in patients with rheumatoid arthritis: meta-analysis of registries and systematic review of long-term extension studiesPierre Le Blay, Gael Mouterde, Thomas Barnetche, et al.
Presse Medicale (Paris, France : 1983)|May 25, 2010
[Postoperative discitis due to Propionibacterium acnes]Yves-Marie Pers, Johana Chekroun, Cédric Lukas, et al.
Rheumatology (Oxford, England)|August 20, 2009
Mesenteric and splenic cat-scratch disease during etanercept therapyAurélie Schiffmann, Yves Marie Pers, Cédric Lukas, et al.
Pageof 20